{"id":"clobetasol-propionate-0-05","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Systemic corticosteroid absorption (with prolonged use or occlusion)"},{"rate":null,"effect":"Contact dermatitis"}]},"_chembl":{"chemblId":"CHEMBL1159650","moleculeType":"Small molecule","molecularWeight":"466.98"},"_dailymed":{"setId":"d40ea303-9eba-4750-955d-6bb005882fb5","title":"CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% (CLOBETASOL PROPIONATE USP, 0.05%) CREAM [A-S MEDICATION SOLUTIONS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a Class I (super-potent) topical corticosteroid, clobetasol propionate activates intracellular glucocorticoid receptors, leading to decreased production of inflammatory mediators and reduced immune cell infiltration. This results in rapid anti-inflammatory, antipruritic, and vasoconstrictive effects on affected skin. The 0.05% formulation is among the highest-strength topical corticosteroids available.","oneSentence":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:13.765Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema)"},{"name":"Alopecia areata"},{"name":"Lichen sclerosus"}]},"trialDetails":[{"nctId":"NCT04563923","phase":"PHASE2","title":"Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2020-10-10","conditions":"Bullous Pemphigoid","enrollment":15},{"nctId":"NCT03926299","phase":"NA","title":"Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Prof. Dr. Volker Viereck","startDate":"2019-07-15","conditions":"Chronic Skin Disease, Vulvar Lichen Sclerosus","enrollment":66},{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT07398807","phase":"EARLY_PHASE1","title":"Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo","status":"RECRUITING","sponsor":"Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan","startDate":"2025-08-08","conditions":"Vitiligo","enrollment":40},{"nctId":"NCT07278999","phase":"NA","title":"Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of Oral Lichen Planus.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-12-01","conditions":"Oral Lichen Planus, Erosive Lichen Planus, Mucosal Lesions","enrollment":60},{"nctId":"NCT07276802","phase":"PHASE4","title":"The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)","status":"NOT_YET_RECRUITING","sponsor":"Research Insight LLC","startDate":"2025-12-05","conditions":"Post Cataract Surgery","enrollment":40},{"nctId":"NCT05010421","phase":"PHASE3","title":"Laser vs Clobetasol for Lichen Sclerosus","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2021-11-02","conditions":"Lichen Sclerosus","enrollment":246},{"nctId":"NCT07240519","phase":"NA","title":"To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.","status":"RECRUITING","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2022-06-22","conditions":"Vulvar Lichen Sclerosus","enrollment":40},{"nctId":"NCT06742333","phase":"PHASE2","title":"Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2025-07-22","conditions":"Psoriasis","enrollment":40},{"nctId":"NCT07240389","phase":"NA","title":"Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.","status":"NOT_YET_RECRUITING","sponsor":"Milosz Pietrus","startDate":"2025-12-01","conditions":"Vulvar Lichen Sclerosus","enrollment":45},{"nctId":"NCT06856590","phase":"NA","title":"ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction","status":"COMPLETED","sponsor":"Gazi University","startDate":"2025-02-20","conditions":"Hand-Foot Skin Reaction (HFSR)","enrollment":150},{"nctId":"NCT07100613","phase":"PHASE2","title":"Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus","status":"RECRUITING","sponsor":"University of Palermo","startDate":"2024-09-04","conditions":"Oral Lichen Planus, Oral Lichen Planus Related Stress, Oral Mucosal Disease","enrollment":45},{"nctId":"NCT05243563","phase":"PHASE2, PHASE3","title":"Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?","status":"TERMINATED","sponsor":"University of South Alabama","startDate":"2022-04-13","conditions":"Vulvar Lichen Sclerosus","enrollment":11},{"nctId":"NCT01557517","phase":"PHASE2","title":"Clobetasol for Oral Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-03-28","conditions":"Oral Chronic Graft vs Host Disease","enrollment":40},{"nctId":"NCT04951206","phase":"PHASE4","title":"Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2022-03-01","conditions":"Vulvar Lichen Sclerosus","enrollment":212},{"nctId":"NCT05364515","phase":"PHASE3","title":"Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva","status":"WITHDRAWN","sponsor":"Fundación Eduardo Anitua","startDate":"2021-12-23","conditions":"Lichen Sclerosus of Vulva","enrollment":""},{"nctId":"NCT02392130","phase":"PHASE1","title":"A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-03","conditions":"Skin Tissue Diseases, Connective Tissue Diseases","enrollment":40},{"nctId":"NCT02376049","phase":"PHASE1","title":"A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-02","conditions":"Atopic Dermatitis","enrollment":30},{"nctId":"NCT02355639","phase":"PHASE1","title":"A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Skin and Connective Tissue Diseases","enrollment":16},{"nctId":"NCT05724446","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population","status":"RECRUITING","sponsor":"Salvat","startDate":"2022-12-12","conditions":"Cataracts Infantile","enrollment":60},{"nctId":"NCT06555497","phase":"EARLY_PHASE1","title":"Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis","status":"COMPLETED","sponsor":"Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium","startDate":"2022-01-01","conditions":"Pilot Study, Psoriasis","enrollment":2},{"nctId":"NCT06042647","phase":"PHASE4","title":"Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis","status":"COMPLETED","sponsor":"Dermatology Consulting Services, PLLC","startDate":"2023-07-13","conditions":"Psoriasis Vulgaris","enrollment":10},{"nctId":"NCT06119672","phase":"PHASE3","title":"Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-05-01","conditions":"Oral Lichen Planus","enrollment":36},{"nctId":"NCT00400725","phase":"PHASE3","title":"Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-09-29","conditions":"Scalp Psoriasis","enrollment":288},{"nctId":"NCT05885269","phase":"PHASE1","title":"Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2022-11-01","conditions":"Alopecia Areata","enrollment":70},{"nctId":"NCT04246801","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)","status":"COMPLETED","sponsor":"Salvat","startDate":"2020-06-10","conditions":"Cataract","enrollment":250},{"nctId":"NCT04249076","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)","status":"COMPLETED","sponsor":"Salvat","startDate":"2020-06-04","conditions":"Cataract","enrollment":215},{"nctId":"NCT01893567","phase":"PHASE4","title":"Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2013-07","conditions":"Plaque Psoriasis","enrollment":28},{"nctId":"NCT00881868","phase":"PHASE4","title":"Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-04","conditions":"Scalp Psoriasis","enrollment":81},{"nctId":"NCT00733954","phase":"PHASE4","title":"Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-08","conditions":"Plaque Psoriasis","enrollment":250},{"nctId":"NCT00658788","phase":"PHASE3","title":"Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-03","conditions":"Psoriasis","enrollment":305},{"nctId":"NCT00988637","phase":"PHASE4","title":"Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-10","conditions":"Plaque Psoriasis","enrollment":138},{"nctId":"NCT00437255","phase":"PHASE4","title":"Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-08","conditions":"Plaque Psoriasis","enrollment":122},{"nctId":"NCT00436540","phase":"PHASE4","title":"A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-03","conditions":"Psoriasis","enrollment":78},{"nctId":"NCT00437216","phase":"","title":"Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-02","conditions":"Psoriasis","enrollment":2488},{"nctId":"NCT01126255","phase":"PHASE2","title":"Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus","status":"TERMINATED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2011-03","conditions":"Vulvar Lichen Sclerosus","enrollment":37},{"nctId":"NCT00803439","phase":"","title":"Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2005-04","conditions":"Healthy","enrollment":80},{"nctId":"NCT02573883","phase":"PHASE3","title":"Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2015-10","conditions":"Vulvar Lichen Sclerosus","enrollment":52},{"nctId":"NCT03779360","phase":"NA","title":"Intradermal LPS and Antibiotics","status":"COMPLETED","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2018-10-12","conditions":"Inflammation; Skin","enrollment":32},{"nctId":"NCT03847389","phase":"PHASE1, PHASE2","title":"Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis","status":"TERMINATED","sponsor":"Hill Dermaceuticals, Inc.","startDate":"2019-09-09","conditions":"Atopic Dermatitis","enrollment":8},{"nctId":"NCT01282515","phase":"PHASE2, PHASE3","title":"Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2011-08","conditions":"Genital Lichen Planus","enrollment":40},{"nctId":"NCT00438399","phase":"PHASE3","title":"Subject Preference for Scalp Psoriasis Treatment","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Scalp Psoriasis","enrollment":219},{"nctId":"NCT00862654","phase":"PHASE3","title":"Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-03","conditions":"Scalp Seborrheic Dermatitis","enrollment":326},{"nctId":"NCT04719559","phase":"NA","title":"Fractional Laser and Steroid Ointment to Improve the Old Scar After Thyroidectomy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-03-20","conditions":"Thyroid; Wound, Steroid Acne","enrollment":10},{"nctId":"NCT04673916","phase":"NA","title":"Treatment Protocols for Patients With Symptomatic Oral Lichen Planus","status":"COMPLETED","sponsor":"University of Messina","startDate":"2019-06-01","conditions":"Lichen Planus, Oral, Preneoplastic Condition","enrollment":61},{"nctId":"NCT03878771","phase":"PHASE1","title":"PRF in Management of Chronic Multiple Oral Ulcers","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2019-03-13","conditions":"Oral Ulcer Due to Pemphius Vularis, Oral Ulcer Due to Benign Mucous Membrane Pemphioid, Oral Ulcer Due to Steven Johnson's Syndrome","enrollment":804},{"nctId":"NCT03961126","phase":"PHASE2","title":"Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2017-09-06","conditions":"Vulvar Lichen Sclerosus","enrollment":20},{"nctId":"NCT03386643","phase":"PHASE2","title":"Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-11-06","conditions":"Oral Lichen Planus","enrollment":22},{"nctId":"NCT03983460","phase":"NA","title":"Dupilumab Impact on Skin Resident Memory T Cells","status":"UNKNOWN","sponsor":"Association pour la Recherche Clinique et Immunologique","startDate":"2020-03-09","conditions":"Atopic Dermatitis","enrollment":20},{"nctId":"NCT03758365","phase":"PHASE1","title":"Evaluation of the Vasoconstriction Properties of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-11-05","conditions":"Vasoconstriction","enrollment":36},{"nctId":"NCT03286582","phase":"PHASE2","title":"A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid","status":"TERMINATED","sponsor":"TWi Biotechnology, Inc.","startDate":"2017-09-05","conditions":"Bullous Pemphigoid","enrollment":10},{"nctId":"NCT02319616","phase":"PHASE1, PHASE2","title":"Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2016-11","conditions":"Toxic Epidermal Necrolysis","enrollment":""},{"nctId":"NCT00864500","phase":"PHASE1","title":"Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2005-11","conditions":"Healthy","enrollment":224},{"nctId":"NCT00864240","phase":"PHASE1","title":"The Dose-response \"Pilot\" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2005-10","conditions":"Healthy","enrollment":15},{"nctId":"NCT03320460","phase":"NA","title":"Photobiomodulation in Oral Lichen Planus","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2018-11-01","conditions":"Lichen Planus, Oral, Low-Level Light Therapy","enrollment":44},{"nctId":"NCT01235442","phase":"PHASE3","title":"Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-09","conditions":"Psoriasis","enrollment":592},{"nctId":"NCT02123966","phase":"PHASE2","title":"An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease","status":"TERMINATED","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-07","conditions":"Chronic Graft-versus-Host-Disease, Oral Mucosal Disease Due to Graft-versus-host Disease","enrollment":10},{"nctId":"NCT02680717","phase":"PHASE1","title":"Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2016-03","conditions":"Scleroderma","enrollment":""},{"nctId":"NCT01323673","phase":"PHASE4","title":"Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-11-15","conditions":"Dermatitis, Chronic","enrollment":125},{"nctId":"NCT03535233","phase":"PHASE4","title":"Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-03","conditions":"Alopecia Areata","enrollment":40},{"nctId":"NCT02131324","phase":"PHASE2","title":"DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Promius Pharma, LLC","startDate":"2014-05-08","conditions":"Psoriasis","enrollment":50},{"nctId":"NCT03026478","phase":"PHASE2","title":"Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus","status":"UNKNOWN","sponsor":"Garlapati Komali","startDate":"2016-05-06","conditions":"Oral Lichen Planus","enrollment":30},{"nctId":"NCT03453190","phase":"PHASE4","title":"Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis","status":"UNKNOWN","sponsor":"Washington Dermatology Center","startDate":"2018-02-25","conditions":"Psoriasis","enrollment":20},{"nctId":"NCT03399526","phase":"PHASE1","title":"1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-02-11","conditions":"Psoriasis","enrollment":24},{"nctId":"NCT02416531","phase":"NA","title":"Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser","status":"COMPLETED","sponsor":"Daniela de Fátima Teixeira da Silva","startDate":"2015-01","conditions":"Vulvar Lichen Sclerosus","enrollment":30},{"nctId":"NCT02973776","phase":"PHASE1","title":"Vasoconstriction Trial With LEO 90100 Aerosol Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-12","conditions":"Psoriasis Vulgaris","enrollment":36},{"nctId":"NCT02940002","phase":"PHASE1","title":"BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-10-12","conditions":"Psoriasis","enrollment":23},{"nctId":"NCT01313221","phase":"PHASE3","title":"Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-04","conditions":"Psoriasis","enrollment":310},{"nctId":"NCT01745133","phase":"PHASE4","title":"Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Leon Kircik, M.D.","startDate":"2013-01","conditions":"Psoriasis","enrollment":63},{"nctId":"NCT00470392","phase":"NA","title":"Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2007-05","conditions":"Psoriasis","enrollment":9},{"nctId":"NCT02492373","phase":"NA","title":"Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2015-02","conditions":"Lentigines, Post Inflammatory Hyperpigmentation","enrollment":21},{"nctId":"NCT02744378","phase":"PHASE2","title":"Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus","status":"COMPLETED","sponsor":"University of Peradeniya","startDate":"2014-06","conditions":"Oral Lichen Planus","enrollment":68},{"nctId":"NCT01987076","phase":"NA","title":"Comparison Between Corticosteroid and Topical Steroids in the DRESS","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-10","conditions":"Drug Rash With Eosinophilia and Systemic Symptoms","enrollment":112},{"nctId":"NCT01407471","phase":"PHASE2","title":"Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-09","conditions":"Cutaneous Atrophy Due to Corticosteroids","enrollment":26},{"nctId":"NCT02487212","phase":"PHASE4","title":"Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-04","conditions":"Hypertrophic Scars","enrollment":24},{"nctId":"NCT00393263","phase":"PHASE2","title":"Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Center for Vulvovaginal Disorders","startDate":"2006-10","conditions":"Lichen Sclerosus","enrollment":38},{"nctId":"NCT01453686","phase":"PHASE3","title":"A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2002-08","conditions":"Alopecia Areata","enrollment":41},{"nctId":"NCT01400022","phase":"NA","title":"Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2010-08","conditions":"Vulvar Lichen Sclerosus","enrollment":30},{"nctId":"NCT01703325","phase":"PHASE4","title":"Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2010-11","conditions":"Psoriatic Nails","enrollment":16},{"nctId":"NCT01699412","phase":"PHASE3","title":"Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease","status":"COMPLETED","sponsor":"Grupo de Estudos Multicentricos em Onco-Hematologia","startDate":"2008-08","conditions":"Graft vs Host Disease, Oral Manifestations","enrollment":28},{"nctId":"NCT00852761","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-03","conditions":"Plaque-Type Psoriasis","enrollment":34},{"nctId":"NCT01111981","phase":"PHASE4","title":"Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia","status":"UNKNOWN","sponsor":"Callender Center for Clinical Research","startDate":"2009-10","conditions":"Alopecia","enrollment":30},{"nctId":"NCT00102557","phase":"PHASE2","title":"Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus","status":"COMPLETED","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"2005-01","conditions":"Lichen Planus, Oral","enrollment":74}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":193,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Clobex® Spray","Clobex® Spray, 0.05%"],"phase":"marketed","status":"active","brandName":"Clobetasol Propionate, 0.05%","genericName":"Clobetasol Propionate, 0.05%","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema), Alopecia areata, Lichen sclerosus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}